Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy. - Wikidata - wikimedia - TriplyDB

Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.

Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.

http://www.wikidata.org/entity/Q36010195

about

Targeting cellular metabolism to improve cancer therapeutics The Warburg effect and drug resistance Cancer Metabolism and Drug Resistance Novel therapeutic targets of tumor metabolism Immunometabolism in Tuberculosis Isoform-selective inhibition of facilitative glucose transporters: elucidation of the molecular mechanism of HIV protease inhibitor binding.Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?Expression and phosphorylation of the AS160_v2 splice variant supports GLUT4 activation and the Warburg effect in multiple myeloma.Identification of p38β as a therapeutic target for the treatment of Sézary syndrome.In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy.Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells Broad targeting of resistance to apoptosis in cancer.Nutrient transporters: the Achilles' heel of anabolism.Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance.Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET.NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer.PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy.Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.Hepatic expression and cellular distribution of the glucose transporter family.Tankyrases: structure, function and therapeutic implications in cancer.Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.Regulation of Cancer Cell Behavior by the Small GTPase Rab13 Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax.The PI3K pathway in B cell metabolism Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?Strategies to Target Glucose Metabolism in Tumor Microenvironment on Cancer by Flavonoids.Glucose transporters: physiological and pathological roles.Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma.Histone deacetylase 6 (HDAC6) promotes the pro-survival activity of 14-3-3ζ via deacetylation of lysines within the 14-3-3ζ binding pocket.Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.Metabolic Links between Plasma Cell Survival, Secretion, and Stress.(11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment.Development of GLUT4-selective antagonists for multiple myeloma therapy.Evaluating the Efficacy of GLUT Inhibitors Using a Seahorse Extracellular Flux Analyzer.Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer.Current Opinions on Chemoresistance: An Overview.Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1.

P2860

Q24596727-23BDDA67-4FB4-4650-BAEA-3500F9B87298 Q26770007-33E3D144-FDDA-429C-A7A9-4467123B7908 Q26782042-573BD25E-863C-4169-93D9-3E1F9CC5682A Q27005930-4AE5DD4F-A220-4AF5-BB82-D6147106C3FA Q27021247-2327A06D-D321-4307-BF66-EA67775AEAD7 Q33718467-3A98CD44-2DBF-412C-8E7B-7352648312AD Q33917658-450A6EBA-12E6-4227-8A7E-66A592D40A80 Q34258911-F07A312C-0057-43BB-B7D0-17D4D299F9B8 Q34899213-CC899B8F-D2A4-46DF-80A2-DB6BB5FC6CBC Q35595838-9A92CA4C-2EE6-4EDC-8791-F894EF0ACFF7 Q36208283-295D5F9D-1847-43B5-8C44-ADA647511936 Q36483749-D3E302C0-9029-49DB-B688-D16726F09B1E Q36741646-9B1311D5-34DB-4727-B510-73494730EA9E Q36815271-80E4BEBA-BAF5-4C23-9ED5-C8ABBDE66B98 Q36905125-2EFF1754-C7A9-45EF-87FB-63A848B06026 Q36928877-49E6579C-1090-4A0E-94FE-1F2ACA9BD469 Q37001187-3B769E4E-6B44-4F9C-90C4-0B08CE96A0A9 Q37031827-9DA334E8-6BC3-410C-8C8E-FA362BEBF2FA Q37476025-B0F29DAD-8F15-43FF-872E-59402FB29F4A Q37569456-FA5E4B3E-46E4-4E61-B507-CD5D9BFA8692 Q38067388-2870A076-0025-4C37-BAA0-9180B36BC42F Q38224266-9C5F9AD7-04D0-4DCF-8884-0AC41B29DD94 Q38714538-B7C4202A-0854-4C8D-BA4B-D905AA219502 Q38798155-56DEA495-45F5-4719-80CB-C0B8D51B6486 Q38814114-403BDB16-A6AA-4506-9728-712C9D70FEF6 Q38919518-A3D0DACA-7C1F-4905-B34B-657E387AB117 Q38925161-645E55A8-B994-473E-8EB9-7385C37B3F05 Q39015233-8E31406D-7B71-4941-855B-F3A9E982E3AE Q39190194-9ECFFF63-7ACB-49E6-B65B-EBF71351E384 Q39310744-39260415-1DB3-4620-ADD0-BEBE982B2B32 Q39530606-71A82C15-1C9E-4565-BA13-346C3DF7C563 Q40679799-67251DCE-92B0-4E5E-BB80-DE6EAFA6DC7F Q41471256-388A9305-3C2F-413A-825A-B459C4A14A5C Q41997253-2659A6B3-576F-4E8A-AEFD-B34BCD103DB0 Q43672014-E564388C-4864-4EE4-95B8-9653DE3E477E Q47910184-E5E31863-26E8-46F6-99B6-33AC5AAFA1BB Q50017438-E62F1973-7B3D-4772-A587-45727F7303CE Q52313314-06400F0D-9CBA-40D7-8865-AAB5F88EAF21 Q52721498-20FB6607-3E99-4D7C-8EC6-21FFD56E7930 Q52727826-3AE93C80-ED7D-4E92-BC2F-86F008CCB636

P2860

Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.

http://www.wikidata.org/entity/Q36010195

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Multiple myeloma exhibits nove ...... transporter-directed therapy.

@ast

Multiple myeloma exhibits nove ...... transporter-directed therapy.

@en

type

label

Multiple myeloma exhibits nove ...... transporter-directed therapy.

@ast

Multiple myeloma exhibits nove ...... transporter-directed therapy.

@en

prefLabel

Multiple myeloma exhibits nove ...... transporter-directed therapy.

@ast

Multiple myeloma exhibits nove ...... transporter-directed therapy.

@en

P1433

Q36010195-C2191A2C-4597-4161-9C2F-2766C2F02ADE

P1476

Q36010195-8DEAB8F1-551A-4C90-9337-AF69A6CDABD5

P2093

Q36010195-143A5842-55D6-4D9D-B007-DD446FA22045

Q36010195-C3ADF06D-1892-4DF1-B0BE-ECBED29FBA4C

Q36010195-DD5B8232-D2C9-4B86-9F6B-EADA44EE023F

Q36010195-E5BB4B11-23FE-4E58-BDFA-325E9736239B

Q36010195-EEC0C7B9-942D-451F-B55C-229DA7C8C5A6

Q36010195-F3876487-6736-4DFB-8062-395F1D24AD89

P2860

Q36010195-096AA95B-E3E2-4372-A161-4038443B8968

Q36010195-14E349B4-CACC-43EE-AC5B-2C520E4F0E5E

Q36010195-2F6BE4D9-FE12-40C6-B592-BFE5955E196D

Q36010195-2F8BA7C4-C859-4803-A13F-A186222D2442

Q36010195-34BE1FB1-FEEC-444B-8DB6-BFF2DC5E1E21

Q36010195-365E7E03-89DC-4E7B-B503-A6D9D723D5A3

Q36010195-36CD0FE9-B25C-4A3E-BA66-ED44E90B410C

Q36010195-45B404E3-6ECD-4723-BB5D-A7BFD335138C

Q36010195-48ABBEF8-4D69-4ECF-90FB-4AFAF7C93016

Q36010195-523F9745-E696-4E6E-9FA2-FC5B4D9EE1C1

P304

Q36010195-FF83A236-FF15-48DA-80CF-7372EBE712C7

P31

Q36010195-8FDE5100-F814-462C-B7C5-EFE04BE8171E

P356

Q36010195-75003E21-D032-4F93-B605-2AE69C293502

P407

Q36010195-40638C2E-2342-46B2-8D7B-6D35D45B7FDA

P433

Q36010195-C6D61C39-9E52-4077-B7F3-85EA8BE2B8E1

P478

Q36010195-8687E572-38FC-44BC-815A-451F70C5E6DB

P577

Q36010195-8C66C56E-96B0-4AA8-B1FC-50E93714743D

P5875

Q36010195-84B98CC8-7031-4A26-AE40-FB0E4D0C2A49

P698

Q36010195-75B90BC4-4035-46DD-98E1-25DB81E088E4

P932

Q36010195-43C09E76-94B9-4E72-B3C4-CE5423ADA195

P356

BLOOD-2011-09-377846

P1433

P1476

Multiple myeloma exhibits nove ...... transporter-directed therapy.

@en

P2093

Javelin C Cheng

http://www.w3.org/2001/XMLSchema#string

Mala Shanmugam

http://www.w3.org/2001/XMLSchema#string

Nancy L Krett

http://www.w3.org/2001/XMLSchema#string

Samuel K McBrayer

http://www.w3.org/2001/XMLSchema#string

Seema Singhal

http://www.w3.org/2001/XMLSchema#string

Steven T Rosen

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Understanding the Warburg effect: the metabolic requirements of cell proliferation

GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes

Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C

Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain.

SLC2A9 is a high-capacity urate transporter in humans

Immunolocalization of GLUTX1 in the testis and to specific brain areas and vasopressin-containing neurons

BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis

Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members.

E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation

P304

4686-4697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-09-377846

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221977979

http://www.w3.org/2001/XMLSchema#string

P698

22452979

http://www.w3.org/2001/XMLSchema#string

P932

3367873

http://www.w3.org/2001/XMLSchema#string